Trademark: 77775341
Word
IXAMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY
Status
Pending
Status Code
622
Status Date
Friday, July 10, 2009
Serial Number
77775341
Mark Type
4000
Trademark Owner History
Bristol-Myers Squibb Company
Classifications
42 Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use
Trademark Events
Jul 10, 2009
New Application Entered In Tram
PWR
URBAN ZONE
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov